26, August, 2025
# Sign In
  1. Home
  2. Market Highlights

Market Highlights

Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.

August 26, 2025

  • Daily Morning Report – 26.08.2025
  • NIFTY OUTLOOK: 24967.75 | FII -2466.24 cr | DII 3176.69 cr
  • As discussed yesterday, market behaviour remained on expected lines, with Nifty successfully defending the opening upside gap of 18th August and rallying up to our level of 25021 (day high 25021.55). It closed near our level of 24970 at 24967.75.
  • A small indecisive candle formed within the body of the previous day’s bearish candle, creating a bullish harami cross pattern on the daily chart. The defended gap of 18th August indicates diminishing selling pressure and keeps hopes alive for the bulls.
  • If Nifty crosses 25017, it may rally to 25063–25110, with a further chance to test 25157 if demand strengthens.
  • However, the small candle also signals indecision. A decisive breakdown below 24920 could drag it to 24873–24825, with a chance of testing 24777 if supply increases.
  • Bank Nifty Outlook
  • Spot: 55139.30 | PCR: 0.49 | Max CE OI: 57000 | Max PE OI: 57000
  • On 25th August 2025, Bank Nifty closed at 55139.30 (-10.10, -0.02%). The index moved 257.60 points during the session, with a high of 55306.00 and a low of 55048.40.
  • Technical View:
  • Key support and resistance levels are at 54500 and 55800.
  • Intraday support and resistance are at 55068 and 55210.
  • Intraday Technical Strategy:
  • Go long above 55068 with SL 55186 and target 55280.
  • Go short below 55068 with SL 54990 and target 54995.
  • RSI for Bank Nifty stands at 40.40. A reading below 30 indicates oversold and above 70 overbought.
  • Bank nifty Day SMA Analysis:
  • Bank nifty is trading above 2 out of 8 SMA’s (150, 200 Day).
  • Bank nifty is trading below 6 out of 8 SMA’s. (5, 10, 20, 30, 50,100 Day)
  • One bullish candlestick Pattern was identified in bank nifty.
  • • Long legged Doji Uptrend
  • Macros
  • 1.Dollar index @ 98.21
  • 2.S&P Vix @ 14.79 (+4.01 %)
  • 3.Brent Crude @ 67.99
  • 4.10 Years bond yield @ 4.30
  • Note: Tariff terror is getting more aggravated. India will face an additional 25% tariff from 27th Aug. President Donald Trump told reporters on Monday that China must give the United States magnets, or "we have to charge them 200% tariff or something," amid the ongoing trade dispute between the two nations.
  • China, which is highly sensitive about rare earths and its control over supply, added several rare earth items and magnets to its export restriction list in April in retaliation to U.S. tariff hikes.
  • As far as India is concerned, we need to watch the impact of the additional 25% tariff, keep positions light, and focus on sectors that are not affected by tariffs.
  • ---------------------------------------------
  • Data watch
  • 1.Fiis net long 13.2 % (Highly oversold).
  • 2.Fiis sold 2466 cr in cash segment, bought 205.42 cr in index and 897.83 in stock fut
  • 3.Vix @ 11.75 (+0.17%)
  • 4.Pcr @ 0.77
  • Fiis oi position in Index
  • Fiis added 7887 contracts on long side & 6616 on short side, net they added 1271 contract on long side.
  • Diis booked 1456 contracts
  • Note: Fiis net long position is @ 13.2 % still in highly over sold zone, again fiis buy/sell position is confusing.
  • Fiis net long position has increased from 7.5% to 13.2 in weeks’ time, that is due to shorts covered on highly oversold zone.
  • All eyes will be on 27th August deadline for additional tariffs we may see knee jerk reaction in the market. We need to keep position very lite .
  • ---------------------------------------------
  • Contributed by
  • Ashok bhandari : INH000019549
  • -------------------------------------xxxxxxx-------------------------------------------------------------------xxxxxxx---------------------------------
  • HG INFRA: CO TRANSFERS 26% STAKE IN 3 SOLAR SUBSIDIARIES TO STOCKWELL SOLAR SERVICES
  • Subsidiary H.G. Green Energy sold 26 percent stake each in Bikaner, Muknasar and Paleena solar project units to Stockwell Solar Services Pvt Ltd.
  • The company received ₹26,000 per project in cash consideration.
  • The three entities remain subsidiaries but are no longer wholly owned.
  • The deal is not a related-party transaction and not a slump sale.
  • @beatthestreet10
  • SURAJ ESTATE: CO ACQUIRES LAND IN LOWER PAREL; GDV OF AMBAVAT BHAVAN PROJECT RISES TO ₹130 CR
  • The company purchased a 644 sq. mtr land parcel (RK Mansion) at N.M. Joshi Marg, Lower Parel for ₹64.4 Cr including charges.
  • The land will be merged with the ongoing Ambavat Bhavan project, creating a consolidated 1,310 sq. mtr plot.
  • The project will have a Gross Development Value of \~₹130 Cr with \~0.32 lakh sq. ft. saleable area.
  • Plans include premium 1 & 2 BHK value-luxury residential apartments in Lower Parel, Mumbai.
  • @beatthestreet10
  • GREAT EASTERN: GE SHIPPING EXPANDS FLEET WITH SUEZMAX CRUDE CARRIER PURCHASE
  • The company has contracted to buy a 2010-built Suezmax crude carrier of 164,715 dwt on August 25, 2025.
  • The vessel will join the fleet by Q3 FY26, taking total ownership to 40 vessels aggregating 3.29 mn dwt.
  • Current fleet includes 38 vessels comprising 26 tankers and 12 bulk carriers with near 100 percent utilization.
  • @beatthestreet10
  • LEMON TREE HOTELS: EXPANDS FOOTPRINT WITH NEW PROPERTY IN NASHIK, MAHARASHTRA
  • The company has signed "Keys Select by Lemon Tree Hotels" at Mhasrul, Nashik.
  • The property will feature 50 rooms, a restaurant and a banquet hall.
  • It is located near Nashik Airport (16 km) and Railway Station (15 km), within the industrial belt housing Reliance and Godrej.
  • This adds to the company’s 14 operational hotels in Maharashtra.
  • ORIENT BELL : PROMOTER BOUGHT 0.05 % STAKES ON 22 nd AUG VIA OPEN MARKET
  • ZEE MEDIA CORPORATION : PROMOTER BOUGHT 1.6 % STAKES ON 21st AUG VIA OPEN MARKET
  • SHREE SALASAR INVESTMENT : PROMOTER BOUGHT 1.72 % STAKES ON 22 nd AUG VIA OPEN MARKET
  • INFOBEANS TECHNOLOGIES : PROMOTER SOLD 4.05 % STAKES ON 25 th AUG VIA OPEN MARKET
  • GARNET INTERNATIONAL : PROMOTER BOUGHT 0.21 % STAKES ON 22,25 th AUG VIA OPEN MARKET
  • Jefferies on OMCS
  • Higher risk to HPCL from any potential excise duty hike
  • Prefer BPCL on strong earnings visibility and favorable valuations
  • BPCL - Maintain Buy with TP of Rs 410
  • IOCL - Maintain Buy with TP of Rs 160
  • HPCL - Maintain Underperform; Cut TP to Rs 340 from Rs 360
  • HSBC ON INDIA STRATEGY
  • India Expensive Due To High ROEs, Higher Long-Term Growth Potential, Domestic Appetite For Equities
  • Perceived Risk For India Is Lower Due To Strong & Proactive Regulatory Framework & Institution
  • Near-Term Slow Growth & Long-Term Deterioration In ROEs Are Downside Risks
  • India Is Most Expensive Among The Emerging Markets
  • India Presently Trades At Around 60% Premium To Other Emerging Markets
  • BERNSTEIN ON TITAN
  • Initiates 'Outperform' With Target Price Of ₹4,200
  • Jewellery Demand Is Becoming More Formal, Contemporary & Competition Is Increasing
  • Titan Has Under-Leveraged Growth Optionalities
  • Natural Diamond-LGD Dynamics Threatens Its Studded Jewellery Sales, Which Provide Higher Margins
  • While This Is A Key Long-term Risk, We Think The 1-2 Year Impact May Be Muted
  • Jefferies on Auto Sector
  • Auto registration trends have improved in August month-to-date for tractors (+32%) and 2Ws/trucks (+6-7%), but remained soft for PVs (+1%)
  • Consumers are deferring purchases ahead of a potential GST cut
  • Lower taxes could provide a significant demand boost, especially in 2Ws and small PVs
  • Expect Aug wholesales to rise 8-13% YoY for Eicher/M&M/TVS, but to remain within -5% to +1% YoY for other OEMs
  • Preferred picks are M&M & TVS, followed by Maruti & Eicher
  • UBS ON RELIANCE
  • (CMP: 1,412.60)
  • RESUME BUY
  • TARGET PRICE: ₹1,750
  • Building India's Digital & New Energy Future
  • Jio & Retail Entering A 'Harvesting' Phase
  • Diversified O2C Reduces Cyclicality As New Energy Scales Up In Coming Years
  • Expect New Energy To Start Contributing To EBITDA From FY27
  • See Room For Re-Rating In Stock Given Upcoming Value Unlocking Potential
  • MORGAN STANLEY ON HDFC LIFE
  • Maintains 'Overweight'; Hikes Target Price To ₹890 From ₹840
  • MORGAN STANLEY ON HDFC AMC
  • Maintains 'Equal-Weight'; Hikes Target Price To ₹5,415 From ₹4,910
  • Hikes AUM Forecast By 1% For FY26, FY27, FY28
  • MORGAN STANLEY ON AB CAPITAL
  • Maintains 'Overweight'; Hikes Target Price To ₹330 From ₹320
  • Raise FY27-28 Earnings Estimates For The NBFC Business On Lower Provisions
  • Raise FY26-28 HFC Business Earnings Estimates On Higher Revenues & Lower Operating Costs
  • JPM on Anthem Bio
  • Initiate Neutral, TP Rs 820
  • Anthem is an innovation-led, tech-focused CRDMO with leading capabilities in small molecule & fermentation manufacturing, now expanding into high-growth segments such as ADCs, peptides & oligonucleotides
  • Forecast a 26% EPS CAGR over FY25-28E
  • At 63/52x FY27/28E PER, implying 18%/45% premium to DIVI/sector avg, vals look capped
  • Bernstein on Paytm
  • Recommendation Outperform
  • Target Price : ₹1,200
  • Earlier Target : ₹1,100
  • A buy for the long term
  • Limited room for near-term upside vs. consensus
  • Remain constructive given several catalysts that can drive long-term upside
  • CLSA on Avenue Supermarts
  • Recommendation Outperform
  • Target Price : ₹6,408
  • Maintains High Conviction Outperform with 36% upside
  • Dominating ratings and engagement
  • Consistently lower prices and assortment are keys to DMart's success
  • DMart stands out on the quality of its reviews and number of reviews in metro areas and smaller towns
  • CITI ON HYUNDAI MOTOR
  • Maintains 'Buy' With Target Price Of ₹2,400
  • Demand Outlook Remains Positive In Rural Market, While Urban Demand Remains Lackluster For Now
  • Uncertainty Remains On GST Restructuring, Though Directionally, Lower GST Is Likely To Buoy Demand
  • Premiumisation, Platform Rationalisation & Promotional Activities Are Other Key Focus Areas
  • Reiterated Its Model Launch Pipeline With 26 Launches In Next 5 Years
  • Maintains Double-Digit EBITDA Margin Guidance For FY26
  • MORGAN STANLEY ON AAVAS FINANCIERS
  • Maintains 'Equal-Weight'; Cuts Target Price To ₹1,750 From ₹1,860
  • Cut FY26-28 Loan Growth CAGR Projection To 16% From 18%
  • Lower Longer-Term Loan Growth Assumptions, Driving Lower ROEs & Valuation
  • Morgan Stanley
  • Aavas Financiers: Maintain Equal-weight; cut TP to Rs 1,750 from Rs 1,860
  • HDFC Life: Maintain Overweight; hike TP to Rs 890 from Rs 840
  • SBI Life: Maintain Overweight; hike TP to Rs 2,250 from Rs 2,115
  • ICICI Lombard: Maintain Equal-weight; hike TP to Rs 1,910 from Rs 1,855
  • HDFC AMC: Maintain Equal-weight; hike TP to Rs 5,415 from Rs 4,910
  • AB Capital: Maintain Overweight; hike TP to Rs 330 from Rs 320
  • Investec on Zydus Life
  • Sell, TP Rs 940
  • Post outperformance (6% vs Nifty Pharma -2%) over past 1 mth, risk reward has turned even more unfavourable
  • Street underestimating risks related to mirabegron ER & gRevlimid as both combined contribute >35% of FY26E EBITDA & both could go away with no back up prods; 505b2 strategy can only compensate a bit & may fade away once Gx is available
  • NOMURA ON INDIA CEMENT
  • Industry Moving Towards Higher Pricing
  • GST Cut, Struggling Category C & Brand Upgradation By Category B Cos To Lead To Higher Pricing
  • GST Reduction Could Fast Track The Upgradation & Premiumisation Process
  • Price Hikes Ahead Of GST Cut - West Bengal Announces ₹11/Bag Price Hike
  • Category B Players Improving Pricing - Shree Cem Narrowing The Pricing Gap
  • Category C - Struggling To Maintain Volumes; Losing Market Share
  • BOFA ON SIEMENS
  • Maintains 'Underperform'; Hikes Target Price To ₹2,800 From ₹2,564
  • One Round Of Earnings Cuts Behind, Expect Another
  • Street Remains Overly Optimistic On Smart Infra
  • Digital Industries Segment Hit By Weak Capex
  • Valuations Near Long Term Averages, Earnings To Disappoint
  • BOFA Sec on RIL
  • Buy, TP Rs 1660
  • Connectivity: No. 1 in cellular, fixed broadband & in FWA service by users; Competition remains benign; Est 14% Rev. CAGR
  • Digital biz nascent/likely at inflexion point; BofAe EV of JPL $127bn; Adj for debt/vendor payable, BofAe $109bn equity value
  • Jio at 12.2X FY27E EBITDA vs 13.3X for Bharti India Cellular; Likely discount due to better margins/FCF for Bharti
  • ARISINFRA SOLUTIONS: LAUNCHES LUXURY VILLA PROJECT MERUSRI SUNSCAPE IN BENGALURU WITH MERUSRI DEVELOPERS
  • Project located on IVC Road with 76 villas (52 in Phase 1), sizes 2,410–3,850 sq. ft.
  • Total development area 275,000 sq. ft. with 235,000 sq. ft. saleable and GDV of ₹250+ crore.
  • Project is RERA-compliant with financial closure by Aditya Birla; home loan tie-ups include SBI and Tata Capital.
  • Completion expected in 30–36 months with approvals in progress from HDFC, ICICI, Axis and LIC Housing.
  • HINDUSTAN ZINC : Co. plans to double production to 2 million tonnes with ₹30,000–35,000 crore investment
  • -ANNUAL REPORT
  • AB CAPITAL: Co. received RBI approval for appointment of Ms. Vishakha Mulye as MD & CEO for 5 years
  • Block Deal Alert
  • Sai Life Sciences
  • TPG Asia likely to sell 14.7% stake in Sai Life Sciences in ₹2,500 cr block deal. Base Price ₹860 (~5% discount)
  • U.S ADDITIONAL 25 % TARIFF TAKES EFFECT FROM 9.30 AM TOMORROW
  • BLS INTERNATIONAL: WINS ₹2,055 CR UIDAI WORK ORDER FOR AADHAAR SEVA KENDRAS
  • Order awarded by UIDAI for establishing and running district-level Aadhaar Seva Kendras across India.
  • Contract value is ₹2,055.35 crore including taxes, with a service period of six years.
  • Scope includes Aadhaar enrolment, updates, and related services through appointment and walk-in modes.
  • Sources says Industry Seeks Fin Min Assurance That GST Rate Cuts Won't Result In Duty Inversion - CNBCTV 18
  • Alert: Duty Inversion Is When GST On Inputs Is Higher Than GST On Finished Goods/Svcs
  • Industry To Fin Min: Duty Inversion Will Negate
  • GST Rate Cuts, Prices Won't Come Down
  • Fear Of Rate Cuts Causing Inversion Raised By Tractor Makers, Pharma Cos
  • Fear Of Rate Cuts Causing Inversion Raised By Medical Device Makers, Chemical Cos
  • Fear Of Rate Cuts Causing Inversion Raised Fertiliser, Textile, Insurance Cos
  • Rev Dept Taking Note Of Ind Concerns That GST Rate Cuts May Create Duty Inversion
  • EDELWEISS FINANCIAL: 64.30 lk shares worth ₹64 cr change hands at ₹100/sh in block deal window
  • HSBC ON INDIAN MARKET
  • India is expensive for valid reasons, high RoE, higher long-term growth potential and domestic appetite for equities.
  • Also, we believe the perceived risk for India is lower due to strong and pro-active regulatory framework and institutions. Near-term slow growth and framework and institutions.
  • Near-term slow growth and long-term deterioration in RoE are downside risks, in our view
  • KEC INT Management says Seeing Great Opportunity With Govt Aid
  • Seeing Huge Demand In Middle East & America
  • Labour Availabilty Was A Major Challenge But Is Seeing Recovery
  • NIFTY TO OPEN 68 PTS LOWER
  • PROTEAN EGOV UP 6 % ON BIG ORDER
  • KEC INTERNATIONAL ,MD Says Seeing Great Opportunity With Govt Aid - NDTV PROFIT
  • Seeing Huge Demand In Middle East & America
  • Labour Availabilty Was A Major Challenge But Is Seeing Recovery
  • Manufacturers Have Ramped Up Capacity; Discussions Are Opening Up With China
  • Tower Capacity Constraints Are Also Being Addressed
  • MAIN BOARD IPO LISTING TODAY
  • PATEL RETAIL LIMITED
  • SYMBOL: PATELRMART
  • BSE CODE: 544487
  • ISIN NUMBER: INE0R8B01010
  • IPO PRICE: ₹255/-
  • RETAIL LOT : 58 SHARE
  • FACE VALUE : ₹10/-
  • VIKRAM SOLAR LIMITED
  • SYMBOL: VIKRAMSOLR
  • BSE CODE: 544488
  • ISIN NUMBER: INE078V01014
  • IPO PRICE: ₹332/-
  • RETAIL LOT : 45 SHARE
  • FACE VALUE : ₹10/-
  • SHREEJI SHIPPING LIMITED
  • SYMBOL: SHREEJISPG
  • BSE CODE: 544490
  • ISIN NUMBER: INE1B6101010
  • IPO PRICE: ₹252/-
  • RETAIL LOT : 58 SHARE
  • FACE VALUE : ₹10/-
  • GEM AROMATICS LIMITED
  • SYMBOL: GEMAROMA
  • BSE CODE: 544491
  • ISIN NUMBER: INE06XZ01023
  • IPO PRICE: ₹325/-
  • RETAIL LOT : 46 SHARE
  • FACE VALUE : ₹2/-
  • Happy Listing to All Allottees
  • JPMorgan on INDIA I.T. SECTOR
  • Al deflation manifesting; But price action increases Tiel risk-reward
  • Believe Al will be deflationary in the near-to-mid term
  • Do not think Al will negate the need for IT services permanently deflate the services opportunity
  • Expect 10-20% incremental Al deflation that could deflate growth by 2-3% annually
  • BofA Securities On Sun Pharma
  • Downgrade to Underperform
  • Target cut to ₹1,570 from 1,730
  • Speciality-driven earnings provide some medium-term visibility
  • Co may pursue further specialty acquisitions; Upside is already priced in
  • Most Favoured Nation' clause/newsflow continues to weigh on Ilumya
  • Trades at 32x FY27 P/E vs 10-year average of 25.5x
  • PROFIT BOOKING IN PAPER STOCKS AFTER YESTERDAY'S BLOCKBUSTER RALLY
  • SAI LIFE : 3.2 Cr Shares (15.4% Eq) Worth 2,810.6 Cr Change Hands At ₹874/sh
  • HDFC BANK TURNS EX BONUS TODAY... PRICE ADJUSTED
  • US: IMPOSES ADDITIONAL DUTIES ON INDIAN IMPORTS UNDER EXECUTIVE ORDER 14329
  • Effective August 27, 2025, US Customs will levy new ad valorem duties on Indian products.
  • The duties are imposed under Executive Order 14329 linked to Russian Federation policies.
  • A new tariff heading 9903.01.84 adds an additional 25 percent duty on eligible Indian goods.
  • Exemptions apply to in-transit goods and certain specified categories.
  • US: IMPOSES 25% ADDITIONAL DUTY ON INDIAN PRODUCTS FROM AUGUST 27, KEY SECTORS EXEMPTED
  • Effective August 27, 2025, the US will levy a 25 percent ad valorem duty on Indian imports.
  • Exemptions include steel and iron products, derivative steel and aluminium products, aluminium and copper (semi-finished), passenger vehicles, SUVs, minivans, light trucks, auto parts, and select pharmaceutical products.
  • The measure increases costs for non-exempt exporters while shielding key Indian sectors from tariff impact.
  • Sun Pharma - Big Downgrade
  • BofA on Sun Pharma
  • Downgrade to Underperform from Neutral; Cut TP to Rs 1570 from Rs 1730
  • Speciality – new launch execution remain key
  • Premium valuations at risk
  • MFN news flow continues to be an overhang on its largest speciality drug – Ilumya
  • NAZARA TECHNOLOGIES: FOCUS ON CASUAL GAMING AFTER RMG BAN WITH STRONG PIPELINE OF NEW TITLES
  • Industry grew 16% in 2024; upcoming Big Boss game in CY25 and fresh IPs in CY26 to drive growth.
  • Offline expansion planned via Smaaash relaunch in FY27 and 8–9 new Funky Monkeys centers in FY26.
  • Company raised ₹495 crore at ₹990/share, holds ₹500+ crore cash, and announced stock split and 1:1 bonus.
  • Overseas expansion planned; media reports suggest writ petitions may be filed against RMG ban.
  • JM FINANCIAL: TARGET PRICE ₹1370 (20% UPSIDE).
  • Textile cos in focus on 25% additional TrumpTariff impact, PearlGlobalInd & Bombay Dyeing down nearly 3% each
  • Vodafone Idea falls over 6% after MoS Telecom says, no discussion on any additional package for co
  • Market trades lower, Nifty slips below 24,800, other broader indices down nearly 1% each
  • CONTINUES MOMENTUM ; SHREERAMA MULTI UP 11 % AGAIN
  • MARUTI SUZUKI: PM Modi Says Today is a special day in India’s quest for self-reliance and being a hub for green mobility.
  • At the programme in Hansalpur, e-VITARA will be flagged off. This Battery Electric Vehicle (BEV) is made in India and will be exported to over a hundred nations.
  • In a big boost to our battery ecosystem, production of hybrid battery electrodes will also commence at a plant in Gujarat.
  • NARAYANA HEALTH Management says Don't Think Any Hospital Has Taken A Decision w.r.t To An Insurance Co
  • Have A Reasonable Working Relationship With Insurance Cos
  • OLA ELECTRIC: SECURES PLI CERTIFICATION FOR GEN 3 SCOOTER PORTFOLIO, PROFITABILITY BOOST FROM Q2 FY26
  • Ola’s Gen 2 and Gen 3 scooter lineup is now fully PLI-certified under the government scheme.
  • The certification makes the portfolio eligible for incentives of 13 to 18 percent of sales value till 2028.
  • It covers models including S1 Pro 3kWh/4kWh, S1X series, S1 Pro+, and Roadster X+.
  • Deliveries for new models begin in Navratri 2025, with the S1 Pro Sport from January 2026.
  • V2 RETAIL Management says Expect Uptick In Demand Due To GST Relief
  • GST Revamp Is A Bold Move By The Govt & Is Strategically Timed
  • SEAMEC: PROMOTER BOUGHT ADDITIONAL 0.11 % STAKE ON 25 AUG VIA OPEN MARKET
  • AUROBINDO PHARMA: SUBSIDIARY CURATEQ BIOLOGICS GETS UK MHRA APPROVAL FOR BIOSIMILAR DAZULBYS™
  • CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has received UK MHRA approval for Dazulbys (trastuzumab biosimilar).
  • The product was earlier approved by the European Commission in July 2025.
  • This marks CuraTeQ’s fourth MHRA-approved biosimilar after Beqvolya, Zefylti, and Dyruppeg.
  • The approval strengthens Aurobindo’s oncology biosimilar portfolio in the EU and UK markets.
  • DIXON TECHNOLOGIES: MANAGEMENT SAYS US TARIFF EXEMPTIONS ON ELECTRONICS A BIG POSITIVE, NO SUPPLY CHAIN DISRUPTIONS
  • Company management said exemptions for electronics from US tariffs are a major positive.
  • It confirmed there are no supply chain disruptions from the US tariff measures.
  • The exemption supports business continuity and export competitiveness.
Panchkarma